50mg vial
Quanta Pharma Semaglutide 5 mg is a GLP-1 receptor agonist peptide studied for its role in metabolic regulation and glycaemic control. It acts as an analogue of the incretin hormone GLP-1, supporting glucose-dependent insulin secretion while modulating appetite-related signalling pathways. The product is supplied as a pharmaceutical-grade lyophilised powder intended for laboratory research use, and includes bacteriostatic water for reconstitution.
Research focus includes:
Appetite regulation — investigated for effects on hunger signalling and caloric intake
Glycaemic control — studied for its influence on insulin response and blood glucose regulation
Body composition — explored in relation to changes in fat mass and overall weight profiles
Cardiometabolic research — examined for potential associations with cardiovascular biomarkers
Pharmacokinetics — characterised by a prolonged half-life supporting once-weekly research protocols
